Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Heart Left Ventricle Function
75%
Mortality
68%
Coronary Artery Disease
68%
Revascularization
68%
Heart Left Ventricle Ejection Fraction
68%
Disease Burden
68%
Protein P53
68%
Myosin Binding Protein C
68%
Cardiac Myosin
68%
Biological Marker
68%
Heart Muscle Injury
68%
Gene
68%
Patient
63%
Cardiovascular System
62%
Hazard Ratio
52%
Therapeutics
29%
Infarction
25%
Myocardium
25%
Protein
19%
Acute Heart Infarction
19%
ST Segment Elevation Myocardial Infarction
19%
Programmed Cell Death
18%
All Cause Mortality
15%
Follow up
15%
Risk Stratification
15%
Marker
12%
Cells
12%
Cell Cycle Arrest
12%
Cell Cycle Checkpoint
12%
Early Diagnosis
9%
Cardiac Troponin
9%
Myocardial Infarction
9%
Confocal Microscopy
9%
Diagnosis
9%
In Vitro
9%
Coronary Artery Bypass Surgery
9%
Assay
9%
Immunoassay
9%
Non ST Segment Elevation Myocardial Infarction
9%
Immunoblotting
9%
Heart Left Ventricle Failure
7%
Metal
7%
Adverse Outcome
7%
Stent
7%
Mortality Rate
7%
Regression Analysis
7%
Cardiogenic Shock
7%
Percutaneous Transluminal Angioplasty
7%
Logistic Regression Analysis
7%
Biochemistry, Genetics and Molecular Biology
Phosphorylation
85%
Binding Protein
68%
Gene
68%
Isoform
65%
Wild Type
48%
Reduction (Chemistry)
29%
Tyrosine
27%
Cell-Free System
8%
Enzymatic Activity
8%
Phorbol-12-Myristate-13-Acetate-Induced Protein 1
6%
Bcl-2-Associated X Protein
6%
POU4F1
6%
Reoxygenation
6%
